In another study of homologous mouse models, more HER2-targeted CAR-T cells were shown to reside in the tumor stroma with the addition of an anti-PD1 antibody, significantly increasing the ability to recognize tumors and maintain T cell persistence. Here, PDCD1 is linked to neoplasm.